Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis

American Journal of Surgical Pathology

Volumn 37, Issue 3, 2013, Pages 434-442

  Rosty, Christophe ^a,b,c   Walsh, Michael D ^a   Walters, Rhiannon J ^a   Clendenning, Mark ^a   Pearson, Sally Ann ^a   Jenkins, Mark A ^d   Win, Aung Ko ^d   Hopper, John L ^d   Sweet, Kevin ⁱ   Frankel, Wendy L ^j   Aronson, Melyssa ^k   Gallinger, Steve ^k   Goldblatt, Jack ^e,f   Tucker, Kathy ^g   Greening, Sian ^h   Gattas, Michael R ^c   Woodall, Sonja ^l   Arnold, Julie ^l   Walker, Neal I ^c   Parry, Susan ^l,m   Young, Joanne P ^a   Buchanan, Daniel D ^a   more..

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f Genetic Services of Western Australia   (Australia)

^g PRINCE OF WALES HOSPITAL   (Australia)

^h WOLLONGONG HOSPITAL   (Australia)

ⁱ Department of Internal Medicine   (United States)

^j OHIO STATE UNIVERSITY   (United States)

^k MOUNT SINAI HOSPITAL   (Canada)

^l AUCKLAND CITY HOSPITAL   (New Zealand)

^m MIDDLEMORE HOSPITAL   (New Zealand)

more..

Author keywords

colorectal cancer; molecular pathway; serrated polyposis

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; COLON POLYP; COLORECTAL TUMOR; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; COLONIC POLYPS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84873994073     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318270f748     Document Type: Article

References (50)

1. Taylor DP, Burt RW, Williams MS, et al. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology. 2010;138:877-885.
2. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. 2011. Available at: http://www.dietandcancer report.org/. Accessed September 12, 2012.
3. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78-85.
4. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a metaanalysis. Eur J Cancer. 2006;42:216-227.
5. Jass JR. Colorectal polyposes: from phenotype to diagnosis. Pathol Res Pract. 2008;204:431-447.
6. Jaeger E, Leedham S, Lewis A, et al. Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1. Nat Genet. 2012;44:699-703.
7. Boparai KS, Reitsma JB, Lemmens V, et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut. 2010;59:1222-1225.
8. Boparai KS, Mathus-Vliegen EM, Koornstra JJ, et al. Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut. 2010;59: 1094-1100.
9. Buchanan DD, Sweet K, Drini M, et al. Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS ONE. 2010;5:e11636.
10. Buchanan DD, Sweet K, Drini M, et al. Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis. 2010;25:703-712.
11. Kalady MF, Jarrar A, Leach B, et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum. 2011;54:164-170.
12. Edelstein DL, Axilbund JE, Hylind LM, et al. Serrated polyposis: rapid and relentless development of colorectal neoplasia. Gut. 2012. [Epub ahead of print].
13. Win AK, Walters RJ, Buchanan DD, et al. Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol. 2012;107: 770-778.
14. Rosty C, Buchanan DD, Walsh MD, et al. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol. 2012;36:876-882.
15. Jass JR, Whitehall VL, Young J, et al. Emerging concepts in colorectal neoplasia. Gastroenterology. 2002;123:862-876.
16. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010;138:2088-2100.
17. Snover DC, Ahnen DJ, Burt RW, et al. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010:160-165.
18. Walsh MD, Cummings MC, Buchanan DD, et al. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Clin Cancer Res. 2008;14:1692-1700.
19. Newcomb PA, Baron J, Cotterchio M, et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:2331-2343.
20. Carvajal-Carmona LG, Howarth KM, Lockett M, et al. Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol. 2007;212:378-385.
21. Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology. 2006;131:30-39.
22. Yeoman A, Young J, Arnold J, et al. Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry. N Z Med J. 2007;120:U2827.
23. Lockett MJ, Atkin WS. Hyperplastic polyposis: prevalence and cancer risk. Gut. 2001;48:A4.
24. Crowder CD, Sweet K, Lehman A, et al. Serrated Polyposis Is an Underdiagnosed and Unclear Syndrome: The Surgical Pathologist has a Role in Improving Detection. Am J Surg Pathol. 2012;36: 1178-1185.
25. Vemulapalli KC, Rex DK. Failure to recognize serrated polyposis syndrome in a cohort with large sessile colorectal polyps. Gastrointest Endosc. 2012;75:1206-1210.
26. Buchanan DD, Roberts A, Walsh MD, et al. Lessons from Lynch syndrome: a tumor biology-based approach to familial colorectal cancer. Future Oncol. 2010;6:539-549.
27. Dahlin AM, Palmqvist R, Henriksson ML, et al. The role of the CpG island methylator phenotype in colorectal cancer prognosis depends on microsatellite instability screening status. Clin Cancer Res. 2010;16:1845-1855.
28. English DR, Young JP, Simpson JA, et al. Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev. 2008;17:1774-1780.
29. Ogino S, Shima K, Meyerhardt JA, et al. Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803. Clin Cancer Res. 2012;18:890-900.
30. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113-130.
31. Samowitz WS, Sweeney C, Herrick J, et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res. 2005;65:6063-6069.
32. Boparai KS, Dekker E, Polak MM, et al. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am J Pathol. 2011; 178:2700-2707.
33. Yachida S, Mudali S, Martin SA, et al. Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation. Am J Surg Pathol. 2009;33:1823-1832.
34. Pai RK, Mackinnon AC, Joseph L, et al. Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas. Am J Surg Pathol. 2010;34:355-363.
35. Rosty C, Parry S, Young JP. Serrated polyposis: an enigmatic model of colorectal cancer predisposition. Pathol Res Int. 2011;2011: 157073. doi:10.4061/2011/157073.
36. Mulder SA, Kranse R, Damhuis RA, et al. The incidence and risk factors of metachronous colorectal cancer: an indication for followup. Dis Colon Rectum. 2012;55:522-531.
37. Fante R, Roncucci L, Di Gregorio C, et al. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma. Cancer. 1996;77:2013-2021.
38. Jass JR, Cottier DS, Pokos V, et al. Mixed epithelial polyps in association with hereditary non-polyposis colorectal cancer providing an alternative pathway of cancer histogenesis. Pathology. 1997;29:28-33.
39. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology. 1996;110:748-755.
40. Parry S, Win AK, Parry B, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 2011;60:950-957.
41. Arain MA, Sawhney M, Sheikh S, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol. 2010;105:1189-1195.
42. Bressler B, Paszat LF, Chen Z, et al. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 2007;132:96-102.
43. Kahi CJ, Hewett DG, Norton DL, et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol. 2011;9:42-46.
44. Goldstein NS. Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am J Clin Pathol. 2006;125:132-145.
45. Higuchi T, Sugihara K, Jass JR. Demographic and pathological characteristics of serrated polyps of colorectum. Histopathology. 2005;47:32-40.
46. Young JP, Parry S. Risk factors: Hyperplastic polyposis syndrome and risk of colorectal cancer. Nat Rev Gastroenterol Hepatol. 2010;7:594-595.
47. East JE, Saunders BP, Jass JR. Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am. 2008;37:25-46, v.
48. Lynch PM. Hyperplastic polyposis: semantics, biology, and endoscopy. Gut. 2010;59:1019-1021.
49. Burke CA, Snover DC. Editorial: sessile serrated adenomas and their pit patterns: we must first see the forest through the trees. Am J Gastroenterol. 2012;107:470-472.
50. Boparai KS, van den Broek FJ, van Eeden S, et al. Increased polyp detection using narrow band imaging compared with high resolution endoscopy in patients with hyperplastic polyposis syndrome. Endoscopy. 2011;43:676-682.